يعرض 1 - 10 نتائج من 124 نتيجة بحث عن '"Breast cancer chemotherapy"', وقت الاستعلام: 1.00s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial.

    المؤلفون: Möbus, V1 volker.moebus@klinikumfrankfurt.de, Jackisch, C2, Lück, H J3, Bois, A du4, Thomssen, C5, Kuhn, W6, Nitz, U7, Schneeweiss, A8, Huober, J9, Harbeck, N10

    المصدر: Annals of Oncology. Jan2018, Vol. 29 Issue 1, p178-185. 8p. 1 Diagram, 3 Charts, 2 Graphs.

    مصطلحات موضوعية: *MYELODYSPLASTIC syndromes, *MENOPAUSE, *FOLLOW-up studies (Medicine), *MEDICAL statistics, BREAST cancer chemotherapy

    النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer.

    المؤلفون: Criscitiello, C1, Bayar, M A2, Curigliano, G1, Symmans, F W3, Desmedt, C4, Bonnefoi, H5, Sinn, B3, Pruneri, G6, Vicier, C7, Pierga, J Y8

    المصدر: Annals of Oncology. Jan2018, Vol. 29 Issue 1, p162-169. 8p. 4 Charts, 1 Graph.

    مصطلحات موضوعية: *LYMPHOCYTES, *GENE expression, *ANTHRACYCLINES, *MEDICAL statistics, BREAST cancer chemotherapy

    النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Industry corner: perspectives and controversies.

    المؤلفون: Germa, C.1, Miller, M.1, Mukhopadhyay, P.1, Hewes, B.2, Caponigro, G.2, Scherer, S. J.1, Hirawat, S.1 samit.hirawat@novartis.com

    المصدر: Annals of Oncology. Aug2017, Vol. 28 Issue 8, p2021-2024. 4p. 1 Chart, 1 Graph.

    مصطلحات موضوعية: *CYCLIN-dependent kinase inhibitors, *DRUG development, *ONCOLOGIC surgery, *METASTASIS, *THERAPEUTICS, BREAST cancer chemotherapy

    النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial.

    المؤلفون: Earl, H. M.1,2,3 hme22@cam.ac.uk, Hiller, L.4, Dunn, J. A.4, Blenkinsop, C.4, Grybowicz, L.5, Vallier, A.-L.5, Gounaris, I.6,7, Abraham, J. E.1,2,3, Hughes-Davies, L.1,8, McAdam, K.8,9, Chan, S.10, Ahmad, R.11, Hickish, T.12, Rea, D.13, Caldas, C.1,2,3,7, Bartlett, J. M. S.14,15, Cameron, D. A.15, Provenzano, E.2,16, Thomas, J.17, Hayward, R. L.15

    المصدر: Annals of Oncology. Aug2017, Vol. 28 Issue 8, p1817-1824. 8p. 1 Diagram, 2 Charts, 2 Graphs.

    مصطلحات موضوعية: *BEVACIZUMAB, *PROGRESSION-free survival, *FOLLOW-up studies (Medicine), BREAST cancer chemotherapy, CANCER histopathology

    النص الكامل

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial.

    المؤلفون: Ali, H. R.1,2 hme22@cam.ac.uk, Dariush, A.3, Thomas, J.4, Provenzano, E.5,6,7, Dunn, J.8, Hiller, L.8, Vallier, A.-L.5,7, Abraham, J.5,7, Piper, T.4, Bartlett, J. M. S.4,9, Cameron, D. A.4, Hayward, L.4, Brenton, J. D.1,5,7, Pharoah, P. D. P.5,7, Irwin, M. J.3, Walton, N. A.3, Earl, H. M.5,7, Caldas, C.1,5,7 carlos.caldas@cruk.cam.ac.uk

    المصدر: Annals of Oncology. Aug2017, Vol. 28 Issue 8, p1832-1835. 4p. 1 Diagram, 1 Chart, 1 Graph.

    مصطلحات موضوعية: *LYMPHOCYTES, *BREAST biopsy, *FLUOROURACIL, *BIOMARKERS, BREAST cancer chemotherapy

    النص الكامل

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial.

    المؤلفون: Leonard, R. C. F.1 r.leonard@imperial.ac.uk, Adamson, D. J. A.2, Bertelli, G.3, Mansi, J.4, Yellowlees, A.5, Dunlop, J.6, Thomas, G. A.1, Coleman, R. E.7, Anderson, R. A.8

    المصدر: Annals of Oncology. Aug2017, Vol. 28 Issue 8, p1811-1816. 6p. 1 Diagram, 2 Charts, 1 Graph.

    مصطلحات موضوعية: *LUTEINIZING hormone releasing hormone agonists, *CHEMOTHERAPY complications, *PREMATURE ovarian failure, *AMENORRHEA, BREAST cancer chemotherapy

    النص الكامل

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Dose-dense FEC followed by docetaxel versus docetaxel plus cyclophosphamide as adjuvant chemotherapy in women with HER2-negative, axillary lymph node-positive early breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)

    المؤلفون: Mavroudis, D.1, Matikas, A.1, Malamos, N.2, Papakotoulas, P.3, Kakolyris, S.4, Boukovinas, I.3, Athanasiadis, A.5, Kentepozidis, N.6, Ziras, N.7, Katsaounis, P.8, Saloustros, E.9, Georgoulias, V.1

    المصدر: Annals of Oncology. Oct2016, Vol. 27 Issue 10, p1873-1878. 6p. 3 Charts, 1 Graph.

    مصطلحات موضوعية: *DOCETAXEL, *CYCLOPHOSPHAMIDE, *ANTHRACYCLINES, *TAXANES, *DRUG side effects, *THERAPEUTICS, BREAST cancer chemotherapy

    النص الكامل

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial.

    المؤلفون: Dieci, M. V.1,2 mariavittoria.dieci@unipd.it, Prat, A.3,4,5, Tagliafico, E.6, Paré, L.4, Ficarra, G.7, Bisagni, G.8, Piacentini, F.9, Generali, D. G.10, Conte, P.1,2, Guarneri, V.1,2

    المصدر: Annals of Oncology. Oct2016, Vol. 27 Issue 10, p1867-1873. 7p. 2 Charts, 3 Graphs.

    مصطلحات موضوعية: *IMMUNOREGULATION, *BREAST biopsy, *LYMPHOCYTES, *MEDICAL statistics, BREAST cancer chemotherapy

    النص الكامل

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Pooled analyses of eribulin in metastatic breast cancer patients with at least one prior chemotherapy.

    المؤلفون: Pivot, X.1 xavierpivot@univ-fcomte.fr, Marmé, F.2, Koenigsberg, R.3,4, Guo, M.5, Berrak, E.6, Wolfer, A.7

    المصدر: Annals of Oncology. Aug2016, Vol. 27 Issue 8, p1525-1531. 7p. 2 Diagrams, 2 Charts, 1 Graph.

    مصطلحات موضوعية: *ERIBULIN, *CANCER invasiveness, *ANTHRACYCLINES, *PROGRESSION-free survival, *CLINICAL trials, *THERAPEUTICS, BREAST cancer chemotherapy

    النص الكامل

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    PIK3CA mutations in HER2-positive breast cancer: an ongoing conundrum.

    المؤلفون: Goel, S.1, Krop, I. E.1 ian_krop@dfci.harvard.edu

    المصدر: Annals of Oncology. Aug2016, Vol. 27 Issue 8, p1368-1372. 5p. 1 Chart.

    مصطلحات موضوعية: *DISEASE relapse, *PHOSPHOINOSITIDES, *SOMATIC mutation, *HER2 protein, *CANCER cell proliferation, BREAST cancer chemotherapy

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث